Insulet
PODD
#1556
Rank
S$18.20 B
Marketcap
S$258.66
Share price
1.12%
Change (1 day)
-16.92%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - Total debt

Total debt on the balance sheet as of December 2025 : S$1.20 Billion

According to Insulet's latest financial reports the company's total debt is S$1.20 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Insulet - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2025-12-31S$1.21 B-35.03%
2024-12-31S$1.87 B0.31%
2023-12-31S$1.86 B-0.5%
2022-12-31S$1.87 B9.12%
2021-12-31S$1.72 B22.89%
2020-12-31S$1.40 B17.07%
2019-12-31S$1.19 B48.01%
2018-12-31S$0.80 B6.8%
2017-12-31S$0.75 B57.23%
2016-12-31S$0.48 B91.83%
2015-12-31S$0.25 B11.99%
2014-12-31S$0.22 B45.42%
2013-12-31S$0.15 B6.69%
2012-12-31S$0.14 B2.8%
2011-12-31S$0.14 B57.16%
2010-12-31S$89.43 M-34.31%
2009-12-31S$0.13 B58.22%
2008-12-31S$86.05 M124.16%
2007-12-31S$38.38 M-14.33%
2006-12-31S$44.8 M175.15%
2005-12-31S$16.28 M90649.52%
2004-12-31S$0.01 M-3.98%
2003-12-31S$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
S$60.85 B 4,949.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$17.59 B 1,360.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$35.63 B 2,857.33%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$53.96 B 4,377.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
S$0.56 B-53.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
S$1.69 B 40.37%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
S$1.76 B 46.41%๐Ÿ‡บ๐Ÿ‡ธ USA